Alternative pathways of non-homologous end joining (NHEJ) in genomic instability and cancer

Translational Cancer Research

Volumn 2, Issue 3, 2013, Pages 163-177

  Dueva, Rositsa ^a   Iliakis, George ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Alternative non homologous end joining pathway (A NHEJ); Cancer; DNA repair; Double strand breaks; Genomic instability; Homologous recombination repair; Non homologous end joining (NHEJ)

Indexed keywords

EID: 84964045835     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2013.05.02     Document Type: Review

References (163)

1. Hall EJ, Giaccia AJ. eds. Radiobiology for the Radiologist. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Lippincott Williams & Wilkins, 2006.
2. Friedberg EC, Walker GC, Siede W, et al. eds. Ellenberger, DNA Repair and Mutagenesis. Washington, DC, USA: ASM Press, 2006.
3. Mills KD, Ferguson DO, Alt FW. The role of DNA breaks in genomic instability and tumorigenesis. Immunol Rev 2003;194:77-95.
4. Wyman C, Kanaar R. DNA double-strand break repair: all's well that ends well. Annu Rev Genet 2006;40:363-83.
5. Helleday T, Lo J, van Gent DC, et al. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amst) 2007;6:923-35.
6. Kinner A, Wu W, Staudt C, et al. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 2008;36:5678-94.
7. Mladenov E, Iliakis G. Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat Res 2011;711:61-72.
8. Li Z, Otevrel T, Gao Y, et al. The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 1995;83:1079-89.
9. DiBiase SJ, Zeng ZC, Chen R, et al. DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Cancer Res 2000;60:1245-53.
10. Wang H, Zeng ZC, Perrault AR, et al. Genetic evidence for the involvement of DNA ligase IV in the DNA-PK-dependent pathway of non-homologous end joining in mammalian cells. Nucleic Acids Res 2001;29:1653-60.
11. Ahnesorg P, Smith P, Jackson SP. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 2006;124:301-13.
12. Ding Q, Reddy YV, Wang W, et al. Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol 2003;23:5836-48.
13. Mahaney BL, Meek K, Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 2009;417:639-50.
14. Lieber MR. The mechanism of human nonhomologous DNA end joining. J Biol Chem 2008;283:1-5.
15. Burma S, Chen BP, Chen DJ. Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 2006;5:1042-8.
16. Iliakis G, Wang H, Perrault AR, et al. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 2004;104:14-20.
17. Ferguson DO, Sekiguchi JM, Chang S, et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A 2000;97:6630-3.
18. Suwaki N, Klare K, Tarsounas M. RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin Cell Dev Biol 2011;22:898-905.
19. Ip SC, Rass U, Blanco MG, et al. Identification of Holliday junction resolvases from humans and yeast. Nature 2008;456:357-61.
20. Ciccia A, Constantinou A, West SC. Identification and characterization of the human mus81-eme1 endonuclease. J Biol Chem 2003;278:25172-8.
21. Rass U, Compton SA, Matos J, et al. Mechanism of Holliday junction resolution by the human GEN1 protein. Genes Dev 2010;24:1559-69.
22. San Filippo J, Sung P, Klein H. Mechanism of eukaryotic homologous recombination. Annu Rev Biochem 2008;77:229-57.
23. Nimonkar AV, Ozsoy AZ, Genschel J, et al. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc Natl Acad Sci U S A 2008;105:16906-11.
24. Nimonkar AV, Genschel J, Kinoshita E, et al. BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev 2011;25:350-62.
25. Karanja KK, Cox SW, Duxin JP, et al. DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network. Cell Cycle 2012;11:3983-96.
26. Wang H, Perrault AR, Takeda Y, et al. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res 2003;31:5377-88.
27. Kabotyanski EB, Gomelsky L, Han JO, et al. Double-strand break repair in Ku86-and XRCC4-deficient cells. Nucleic Acids Res 1998;26:5333-42.
28. Terzoudi GI, Singh SK, Pantelias GE, et al. Premature chromosome condensation reveals DNA-PK independent pathways of chromosome break repair. Int J Oncol 2008;33:871-9.
29. McVey M, Lee SE. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet 2008;24:529-38.
30. Nussenzweig A, Nussenzweig MC. A backup DNA repair pathway moves to the forefront. Cell 2007;131:223-5.
31. Iliakis G. Backup pathways of NHEJ in cells of higher eukaryotes: cell cycle dependence. Radiother Oncol 2009;92:310-5.
32. Boboila C, Alt FW, Schwer B. Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Adv Immunol 2012;116:1-49.
33. Iliakis G, Wu W, Wang M, et al. Backup pathways of nonhomologous end joining may have a dominant role in the formation of chromosome aberrations. in Chromosomal alterations (G. Obe, Vijayalaxmi, Ed.), pp. 67-85. Springer Verlag, Berlin, Heidelberg, New York, 2007.
34. Gostissa M, Alt FW, Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol 2011;29:319-50.
35. Lieber MR. NHEJ and its backup pathways in chromosomal translocations. Nat Struct Mol Biol 2010;17:393-5.
36. Boboila C, Jankovic M, Yan CT, et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci U S A 2010;107:3034-9.
37. Simsek D, Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat Struct Mol Biol 2010;17:410-6.
38. Wu W, Wang M, Mussfeldt T, et al. Enhanced use of backup pathways of NHEJ in G2 in Chinese hamster mutant cells with defects in the classical pathway of NHEJ. Radiat Res 2008;170:512-20.
39. Guirouilh-Barbat J, Huck S, Lopez BS. S-phase progression stimulates both the mutagenic KU-independent pathway and mutagenic processing of KU-dependent intermediates, for nonhomologous end joining. Oncogene 2008;27:1726-36.
40. Wu W, Wang M, Wu W, et al. Repair of radiation induced DNA double strand breaks by backup NHEJ is enhanced in G2. DNA Repair (Amst) 2008;7:329-38.
41. Singh SK, Bednar T, Zhang L, et al. Inhibition of B-NHEJ in plateau-phase cells is not a direct consequence of suppressed growth factor signaling. Int J Radiat Oncol Biol Phys 2012;84:e237-43.
42. Singh SK, Wu W, Zhang L, et al. Widespread dependence of backup NHEJ on growth state: ramifications for the use of DNA-PK inhibitors. Int J Radiat Oncol Biol Phys 2011;79:540-8.
43. Wang H, Rosidi B, Perrault R, et al. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 2005;65:4020-30.
44. Simsek D, Brunet E, Wong SY, et al. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet 2011;7:e1002080.
45. Della-Maria J, Zhou Y, Tsai MS, et al. Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway. J Biol Chem 2011;286:33845-53.
46. Audebert M, Salles B, Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J Biol Chem 2004;279:55117-26.
47. Liang L, Deng L, Nguyen SC, et al. Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks. Nucleic Acids Res 2008;36:3297-310.
48. Paul K, Wang M, Mladenov E, et al. DNA Ligases I and III Cooperate in Alternative Non-Homologous End-Joining in Vertebrates. PLoS One 2013;8:e59505.
49. Caldecott KW. Mammalian DNA single-strand break repair: an X-ra(y)ted affair. Bioessays 2001;23:447-55.
50. Wang M, Wu W, Wu W, et al. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res 2006;34:6170-82.
51. Brown ML, Franco D, Bürkle A, et al. Role of poly(ADP-ribosyl)ation in DNA-PKcs-independent V(D)J recombination. Proc Natl Acad Sci U S A 2002;99:4532-7.
52. Ahmed EA, de Boer P, Philippens ME, et al. Parp1-XRCC1 and the repair of DNA double strand breaks in mouse round spermatids. Mutat Res 2010;683:84-90.
53. Mansour WY, Rhein T, Dahm-Daphi J. The alternative end-joining pathway for repair of DNA double-strand breaks requires PARP1 but is not dependent upon microhomologies. Nucleic Acids Res 2010;38:6065-77.
54. Paddock MN, Bauman AT, Higdon R, et al. Competition between PARP-1 and Ku70 control the decision between high-fidelity and mutagenic DNA repair. DNA Repair (Amst) 2011;10:338-43.
55. Cheng Q, Barboule N, Frit P, et al. Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks. Nucleic Acids Res 2011;39:9605-19.
56. Rosidi B, Wang M, Wu W, et al. Histone H1 functions as a stimulatory factor in backup pathways of NHEJ. Nucleic Acids Res 2008;36:1610-23.
57. Jeggo PA, Geuting V, Löbrich M. The role of homologous recombination in radiation-induced double-strand break repair. Radiother Oncol 2011;101:7-12.
58. Goodarzi AA, Jeggo P, Lobrich M. The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax. DNA Repair (Amst) 2010;9:1273-82.
59. Xie A, Kwok A, Scully R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat Struct Mol Biol 2009;16:814-8.
60. Dinkelmann M, Spehalski E, Stoneham T, et al. Multiple functions of MRN in end-joining pathways during isotype class switching. Nat Struct Mol Biol 2009;16:808-13.
61. Lee-Theilen M, Matthews AJ, Kelly D, et al. CtIP promotes microhomology-mediated alternative end joining during class-switch recombination. Nat Struct Mol Biol 2011;18:75-9.
62. Zhang Y, Jasin M. An essential role for CtIP in chromosomal translocation formation through an alternative end-joining pathway. Nat Struct Mol Biol 2011;18:80-4.
63. Rass E, Grabarz A, Plo I, et al. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat Struct Mol Biol 2009;16:819-24.
64. Zhuang J, Jiang G, Willers H, et al. Exonuclease function of human Mre11 promotes deletional nonhomologous end joining. J Biol Chem 2009;284:30565-73.
65. Zhong Q, Chen CF, Chen PL, et al. BRCA1 facilitates microhomology-mediated end joining of DNA double strand breaks. J Biol Chem 2002;277:28641-7.
66. Kuhfittig-Kulle S, Feldmann E, Odersky A, et al. The mutagenic potential of non-homologous end joining in the absence of the NHEJ core factors Ku70/80, DNA-PKcs and XRCC4-LigIV. Mutagenesis 2007;22:217-33.
67. Elliott B, Richardson C, Jasin M. Chromosomal translocation mechanisms at intronic alu elements in mammalian cells. Mol Cell 2005;17:885-94.
68. Bennardo N, Cheng A, Huang N, et al. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet 2008;4:e1000110.
69. Windhofer F, Wu W, Wang M, et al. Marked dependence on growth state of backup pathways of NHEJ. Int J Radiat Oncol Biol Phys 2007;68:1462-70.
70. Zhuang J, Zhang J, Willers H, et al. Checkpoint kinase 2-mediated phosphorylation of BRCA1 regulates the fidelity of nonhomologous end-joining. Cancer Res 2006;66:1401-8.
71. Zhang J, Willers H, Feng Z, et al. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 2004;24:708-18.
72. Zhong Q, Boyer TG, Chen PL, et al. Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res 2002;62:3966-70.
73. Chen L, Nievera CJ, Lee AY, et al. Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J Biol Chem 2008;283:7713-20.
74. Zhang Y, Gostissa M, Hildebrand DG, et al. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. Adv Immunol 2010;106:93-133.
75. Alt FW, Zhang Y, Meng FL, et al. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 2013;152:417-29.
76. Elliott B, Jasin M. Double-strand breaks and translocations in cancer. Cell Mol Life Sci 2002;59:373-85.
77. Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell 2010;141:27-38.
78. Wang JH, Gostissa M, Yan CT, et al. Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 2009;460:231-6.
79. Wang JH, Alt FW, Gostissa M, et al. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. J Exp Med 2008;205:3079-90.
80. Roth DB. Restraining the V(D)J recombinase. Nat Rev Immunol 2003;3:656-66.
81. Bassing CH, Swat W, Alt FW. The mechanism and regulation of chromosomal V(D)J recombination. Cell 2002;109:S45-55.
82. Jung D, Giallourakis C, Mostoslavsky R, et al. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006;24:541-70.
83. Malu S, Malshetty V, Francis D, et al. Role of non-homologous end joining in V(D)J recombination. Immunol Res 2012;54:233-46.
84. Lieber MR, Ma Y, Pannicke U, et al. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amst) 2004;3:817-26.
85. Schatz DG, Swanson PC. V(D)J recombination: mechanisms of initiation. Annu Rev Genet 2011;45:167-202.
86. Stavnezer J, Guikema JE, Schrader CE. Mechanism and regulation of class switch recombination. Annu Rev Immunol 2008;26:261-92.
87. Xu Z, Zan H, Pone EJ, et al. Immunoglobulin class-switch DNA recombination: induction, targeting and beyond. Nat Rev Immunol 2012;12:517-31.
88. Nussenzweig A, Chen C, da Costa Soares V, et al. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 1996;382:551-5.
89. Frank KM, Sekiguchi JM, Seidl KJ, et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998;396:173-7.
90. Fukumura R, Araki R, Fujimori A, et al. Signal joint formation is also impaired in DNA-dependent protein kinase catalytic subunit knockout cells. J Immunol 2000;165:3883-9.
91. Fukumura R, Araki R, Fujimori A, et al. Murine cell line SX9 bearing a mutation in the dna-pkcs gene exhibits aberrant V(D)J recombination not only in the coding joint but also in the signal joint. J Biol Chem 1998;273:13058-64.
92. Errami A, He DM, Friedl AA, et al. XR-C1, a new CHO cell mutant which is defective in DNA-PKcs, is impaired in both V(D)J coding and signal joint formation. Nucleic Acids Res 1998;26:3146-53.
93. Ouyang H, Nussenzweig A, Kurimasa A, et al. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination In vivo. J Exp Med 1997;186:921-9.
94. Moshous D, Callebaut I, de Chasseval R, et al. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001;105:177-86.
95. Buck D, Malivert L, de Chasseval R, et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006;124:287-99.
96. Buck D, Moshous D, de Chasseval R, et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol 2006;36:224-35.
97. Enders A, Fisch P, Schwarz K, et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 2006;176:5060-8.
98. van der Burg M, Ijspeert H, Verkaik NS, et al. A DNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest 2009;119:91-8.
99. Blunt T, Finnie NJ, Taccioli GE, et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995;80:813-23.
100. Zhu C, Bogue MA, Lim DS, et al. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 1996;86:379-89.
101. Taccioli GE, Amatucci AG, Beamish HJ, et al. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 1998;9:355-66.
102. Mombaerts P, Iacomini J, Johnson RS, et al. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992;68:869-77.
103. Shinkai Y, Rathbun G, Lam KP, et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992;68:855-67.
104. Corneo B, Wendland RL, Deriano L, et al. Rag mutations reveal robust alternative end joining. Nature 2007;449:483-6.
105. Arnal SM, Holub AJ, Salus SS, et al. Non-consensus heptamer sequences destabilize the RAG post-cleavage complex, making ends available to alternative DNA repair pathways. Nucleic Acids Res 2010;38:2944-54.
106. Verkaik NS, Esveldt-van Lange RE, van Heemst D, et al. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur J Immunol 2002;32:701-9.
107. Huye LE, Purugganan MM, Jiang MM, et al. Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol Cell Biol 2002;22:3460-73.
108. Lee GS, Neiditch MB, Salus SS, et al. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 2004;117:171-84.
109. Deriano L, Chaumeil J, Coussens M, et al. The RAG2 C terminus suppresses genomic instability and lymphomagenesis. Nature 2011;471:119-23.
110. Yan CT, Boboila C, Souza EK, et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007;449:478-82.
111. Han L, Yu K. Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells. J Exp Med 2008;205:2745-53.
112. Boboila C, Yan C, Wesemann DR, et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J Exp Med 2010;207:417-27.
113. Kiefer K, Oshinsky J, Kim J, et al. The catalytic subunit of DNA-protein kinase (DNA-PKcs) is not required for Ig class-switch recombination. Proc Natl Acad Sci U S A 2007;104:2843-8.
114. Bosma GC, Kim J, Urich T, et al. DNA-dependent protein kinase activity is not required for immunoglobulin class switching. J Exp Med 2002;196:1483-95.
115. Casellas R, Nussenzweig A, Wuerffel R, et al. Ku80 is required for immunoglobulin isotype switching. EMBO J 1998;17:2404-11.
116. Manis JP, Gu Y, Lansford R, et al. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J Exp Med 1998;187:2081-9.
117. Saribasak H, Maul RW, Cao Z, et al. XRCC1 suppresses somatic hypermutation and promotes alternative nonhomologous end joining in Igh genes. J Exp Med 2011;208:2209-16.
118. Han L, Mao W, Yu K. X-ray repair cross-complementing protein 1 (XRCC1) deficiency enhances class switch recombination and is permissive for alternative end joining. Proc Natl Acad Sci U S A 2012;109:4604-8.
119. Boboila C, Oksenych V, Gostissa M, et al. Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1). Proc Natl Acad Sci U S A 2012;109:2473-8.
120. Simsek D, Furda A, Gao Y, et al. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 2011;471:245-8.
121. Robert I, Dantzer F, Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. J Exp Med 2009;206:1047-56.
122. Shockett P, Stavnezer J. Inhibitors of poly (ADP-ribose) polymerase increase antibody class switching. J Immunol 1993;151:6962-76.
123. Audebert M, Salles B, Calsou P. Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway. Biochem Biophys Res Commun 2008;369:982-8.
124. Sandoval A, Labhart P. High G/C content of cohesive overhangs renders DNA end joining Ku-independent. DNA Repair (Amst) 2004;3:13-21.
125. Zhu C, Mills KD, Ferguson DO, et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002;109:811-21.
126. Du L, Peng R, Björkman A, et al. Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis. J Exp Med 2012;209:291-305.
127. Sattler M, Verma S, Shrikhande G, et al. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J Biol Chem 2000;275:24273-8.
128. Sallmyr A, Fan J, Rassool FV. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair. Cancer Lett 2008;270:1-9.
129. Poplawski T, Blasiak J. BCR/ABL downregulates DNA-PK(CS)-dependent and upregulates backup non-homologous end joining in leukemic cells. Mol Biol Rep 2010;37:2309-15.
130. Mattarucchi E, Guerini V, Rambaldi A, et al. Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia. Genes Chromosomes Cancer 2008;47:625-32.
131. Sallmyr A, Tomkinson AE, Rassool FV. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 2008;112:1413-23.
132. Fan J, Li L, Small D, et al. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy. Blood 2010;116:5298-305.
133. Meek K, Gupta S, Ramsden DA, et al. The DNA-dependent protein kinase: the director at the end. Immunol Rev 2004;200:132-41.
134. Weterings E, Chen DJ. DNA-dependent protein kinase in nonhomologous end joining: a lock with multiple keys? J Cell Biol 2007;179:183-6.
135. Soutoglou E, Dorn JF, Sengupta K, et al. Positional stability of single double-strand breaks in mammalian cells. Nat Cell Biol 2007;9:675-82.
136. Difilippantonio MJ, Zhu J, Chen HT, et al. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000;404:510-4.
137. Weinstock DM, Brunet E, Jasin M. Formation of NHEJ-derived reciprocal chromosomal translocations does not require Ku70. Nat Cell Biol 2007;9:978-81.
138. Bentley J, Diggle CP, Harnden P, et al. DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. Nucleic Acids Res 2004;32:5249-59.
139. D'Adda di Fagagna F, Reaper PM, Clay-Farrace L, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003;426:194-8.
140. Takai H, Smogorzewska A, de Lange T. DNA damage foci at dysfunctional telomeres. Curr Biol 2003;13:1549-56.
141. de Lange T. How telomeres solve the end-protection problem. Science 2009;326:948-52.
142. Espejel S, Franco S, Rodríguez-Perales S, et al. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J 2002;21:2207-19.
143. Fisher TS, Zakian VA. Ku: a multifunctional protein involved in telomere maintenance. DNA Repair (Amst) 2005;4:1215-26.
144. Gilley D, Tanaka H, Hande MP, et al. DNA-PKcs is critical for telomere capping. Proc Natl Acad Sci U S A 2001;98:15084-8.
145. Goytisolo FA, Samper E, Edmonson S, et al. The absence of the dna-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol Cell Biol 2001;21:3642-51.
146. Hsu HL, Gilley D, Galande SA, et al. Ku acts in a unique way at the mammalian telomere to prevent end joining. Genes Dev 2000;14:2807-12.
147. Bombarde O, Boby C, Gomez D, et al. TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends. EMBO J 2010;29:1573-84.
148. Hsu HL, Gilley D, Blackburn EH, et al. Ku is associated with the telomere in mammals. Proc Natl Acad Sci U S A 1999;96:12454-8.
149. Maser RS, Wong KK, Sahin E, et al. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol Cell Biol 2007;27:2253-65.
150. Rai R, Zheng H, He H, et al. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J 2010;29:2598-610.
151. Oh S, Wang Y, Zimbric J, et al. Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction. Nucleic Acids Res 2013;41:1734-49.
152. Farmer H, McCabe N, Lord CJ, et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005;434:917-21.
153. Chen X, Zhong S, Zhu X, et al. Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res 2008;68:3169-77.
154. Tobin LA, Robert C, Rapoport AP, et al. Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias. Oncogene 2013;32:1784-93.
155. Tobin LA, Robert C, Nagaria P, et al. Targeting abnormal DNA repair in therapy-resistant breast cancers. Mol Cancer Res 2012;10:96-107.
156. Fattah F, Lee EH, Weisensel N, et al. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet 2010;6:e1000855.
157. Bothmer A, Robbiani DF, Feldhahn N, et al. 53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination. J Exp Med 2010;207:855-65.
158. Bothmer A, Robbiani DF, Di Virgilio M, et al. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol Cell 2011;42:319-29.
159. Helmink BA, Tubbs AT, Dorsett Y, et al. H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes. Nature 2011;469:245-9.
160. Lundberg R, Mavinakere M, Campbell C. Deficient DNA end joining activity in extracts from fanconi anemia fibroblasts. J Biol Chem 2001;276:9543-9.
161. Perrault R, Wang H, Wang M, et al. Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem 2004;92:781-94.
162. Callén E, Jankovic M, Difilippantonio S, et al. ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell 2007;130:63-75.
163. Bredemeyer AL, Sharma GG, Huang CY, et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 2006;442:466-70.